Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Prism Johnson Q2 FY26: Revenue ₹762 Cr, PAT ₹3 Cr | Arthneeti

Q2 FY26

RQBE): ₹1,731 Crores, up 12.6% YoY (Page 21, 22) . Key concall takeaways from Prism Johnson Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

25 Sept 2026

Prism Johnson Q3 FY26: Revenue ₹1,759 Cr, PAT ₹72 Cr | Arthneeti

Q3 FY26

Consolidated Revenue Q3 FY26: ₹1,759 Cr, up 5.9% YoY** (Page 35) . Key concall takeaways from Prism Johnson Ltd's Q3 FY26 earnings call — and how it ranks…

25 Sept 2026

Prism Johnson Q4 FY26: Revenue ₹2,118 Cr, PAT ₹28 Cr | Arthneeti

Q4 FY26

Consolidated Revenue Q4 FY26:** ₹2,118 crore, up 7.7% YoY (Page 46) . Key concall takeaways from Prism Johnson Ltd's Q4 FY26 earnings call — and how it ranks…

25 Sept 2026

Prism Johnson Q1 FY27: Revenue ₹1,844 Cr, PAT ₹94 Cr | Arthneeti

Q1 FY27

Consolidated Revenue Q1 FY27:** ₹1,844 Cr, up 2.7% YoY (Page 42) . Key concall takeaways from Prism Johnson Ltd's Q1 FY27 earnings call — and how it ranks…

25 Sept 2026

Smartworks Coworking Spaces Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Revenue from operations for Q4FY26: INR 5,197 Mn, a 45% YoY increase from INR 3,584 Mn in Q4FY25 (Page 34). Key concall takeaways from Smartworks Coworking…

25 Sept 2026

Sun Pharma Advanced Research Company Q1 FY21 earnings call: Revenue & Margins | Arthneeti

Q1 FY21

. Key concall takeaways from Sun Pharma Advanced Research Company Ltd's Q1 FY21 earnings call — and how it ranks against sector peers.

25 Sept 2026

Housing & Urban Development Corporation Q2 FY25: Revenue ₹4,706.07 Cr, PAT ₹438.37 Cr | Arthneeti

Q2 FY25

Revenue from Operations for Q2 FY25: ₹4,706.07 crore, up 27% YoY from ₹3,706.41 crore in Q2 FY24 (Page 24). Key concall takeaways from Housing & Urban…

25 Sept 2026

Housing & Urban Development Corporation Q4 FY26: Revenue ₹13,150.40 Cr, PAT ₹4,034.37 Cr | Arthneeti

Q4 FY26

Revenue from Operations for 12 months Q4 FY26: ₹13,150.40 Crore . Key concall takeaways from Housing & Urban Development Corporation Ltd's Q4 FY26 earnings…

25 Sept 2026

Tanla Platforms Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Revenue for Q1 FY27: ₹12,264 Mn, up 17.8% YoY and 4.1% QoQ (Pages 3, 7, 21). Key concall takeaways from Tanla Platforms Ltd's Q1 FY27 earnings call — and how…

25 Sept 2026

Morepen Laboratories Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

575.31 Cr (Page 4) . Key concall takeaways from Morepen Laboratories Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

25 Sept 2026

Morepen Laboratories Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Crores)**: . Key concall takeaways from Morepen Laboratories Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

25 Sept 2026

Morepen Laboratories Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

248 Crores . Key concall takeaways from Morepen Laboratories Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

25 Sept 2026

Morepen Laboratories Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

488 crores, up 17% from Q3 FY25 Rs. Key concall takeaways from Morepen Laboratories Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

25 Sept 2026

Morepen Laboratories Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

472 crore, up 22% year-on-year (YoY) from Rs. Key concall takeaways from Morepen Laboratories Ltd's Q4 FY26 earnings call — and how it ranks against sector…

25 Sept 2026

Madhya Bharat Agro Products Q1 FY25: Capex ₹770 Cr | Arthneeti

Q1 FY25

982 crore . Key concall takeaways from Madhya Bharat Agro Products Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

25 Sept 2026

Madhya Bharat Agro Products Q2 FY25 earnings call: Revenue & Margins | Arthneeti

Q2 FY25

278.3 crore, virtually flat YoY (-0.1%) compared to Q2 FY24 (Rs. Key concall takeaways from Madhya Bharat Agro Products Ltd's Q2 FY25 earnings call — and how…

25 Sept 2026

Balaji Amines Q3 FY24: Revenue ₹392 Cr, PAT ₹56 Cr | Arthneeti

Q3 FY24

Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Key concall takeaways from Balaji Amines Ltd's Q3…

25 Sept 2026

Balaji Amines Q1 FY25: Revenue ₹393 Cr, PAT ₹46 Cr | Arthneeti

Q1 FY25

Q1FY25 consolidated revenue from operations: ₹393 crore, down 16% YoY from ₹469 crore in Q1FY24 (Page 5 & 6). Key concall takeaways from Balaji Amines Ltd's Q1…

25 Sept 2026

Balaji Amines Q3 FY25: Revenue ₹321 Cr, PAT ₹31 Cr | Arthneeti

Q3 FY25

Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…

25 Sept 2026

Balaji Amines Q1 FY26: Revenue ₹367 Cr, PAT ₹37 Cr | Arthneeti

Q1 FY26

Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…

25 Sept 2026